The New Drug Reimbursement Game A Regulator’s Guide to Playing and Winning /
This comprehensive text presents a rigorous framework from within which regulators can respond strategically to the claim by the pharmaceutical industry that lower drug prices today lead to a loss for the population’s future health due to less innovation. It starts with a critical review of the empi...
Κύριος συγγραφέας: | |
---|---|
Συγγραφή απο Οργανισμό/Αρχή: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Adis,
2015.
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Introduction
- Reframing the political economy of new drugs
- The social rate of return on investment in pharmaceutical R&D
- The value of innovation
- The shadow price
- The health shadow price
- The health shadow price and the economic context
- The `pharmaceutical R&D financing' game
- The `pharmacotherapy needs a premium' game
- Conclusion.